相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Fisetin, a Dietary Flavonoid, Induces Cell Cycle Arrest and Apoptosis through Activation of p53 and Inhibition of NF-Kappa B Pathways in Bladder Cancer Cells
Jing Li et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2011)
Extracellular HIV-1 Tat upregulates TNF-α dependent MCP-1/CCL2 production via activation of ERK1/2 pathway in rat hippocampal slice cultures: Inhibition by resveratrol, a polyphenolic phytostilbene
Eun Ok Lee et al.
EXPERIMENTAL NEUROLOGY (2011)
ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease
Pamela Maher et al.
HUMAN MOLECULAR GENETICS (2011)
Huntington's disease: from molecular pathogenesis to clinical treatment
Christopher A. Ross et al.
LANCET NEUROLOGY (2011)
Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila
Camilla Burnett et al.
NATURE (2011)
Pathological roles of MAPK signaling pathways in human diseases
Eun Kyung Kim et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Effects of Mutant Huntingtin on mGluR5-Mediated Dual Signaling Pathways: Implications for Therapeutic Interventions
Shan-Shan Huang et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2010)
Towards the Treatment of Polyglutamine Diseases: The Modulatory Role of Protein Context
A. L. Robertson et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Resveratrol and derivatives for the prevention and treatment of cancer
Simone Fulda
DRUG DISCOVERY TODAY (2010)
Mutant Huntingtin Alters Cell Fate in Response to Microtubule Depolymerization via the GEF-H1-RhoA-ERK Pathway
Hemant Varma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Impaired TrkB-mediated ERK1/2 Activation in Huntington Disease Knock-in Striatal Cells Involves Reduced p52/p46 Shc Expression
Silvia Gines et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1
Michelle Pacholec et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
p75 Neurotrophin Receptor-mediated Apoptosis in Sympathetic Neurons Involves a Biphasic Activation of JNK and Up-regulation of Tumor Necrosis Factor-α-converting Enzyme/ADAM17
Rajappa S. Kenchappa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Metabotropic Glutamate Receptor-Mediated Cell Signaling Pathways Are Altered in a Mouse Model of Huntington's Disease
Fabiola M. Ribeiro et al.
JOURNAL OF NEUROSCIENCE (2010)
BDNF Overexpression in the Forebrain Rescues Huntington's Disease Phenotypes in YAC128 Mice
Yuxiang Xie et al.
JOURNAL OF NEUROSCIENCE (2010)
Resveratrol and cardiovascular health
Manika Das et al.
MOLECULAR ASPECTS OF MEDICINE (2010)
Resveratrol as a Therapeutic Agent for Neurodegenerative Diseases
Albert Y. Sun et al.
MOLECULAR NEUROBIOLOGY (2010)
Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases
Xiao-xia Dong et al.
ACTA PHARMACOLOGICA SINICA (2009)
Resveratrol is Not a Direct Activator of SIRT1 Enzyme Activity
Dirk Beher et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2009)
Involvement of the ERK Signaling Pathway in Fisetin Reduces Invasion and Migration in the Human Lung Cancer Cell Line A549
Yi-Chen Liao et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2009)
Brain-Derived Neurotrophic Factor Reduces Amyloidogenic Processing through Control of SORLA Gene Expression
Michael Rohe et al.
JOURNAL OF NEUROSCIENCE (2009)
BRAIN-DERIVED NEUROTROPHIC FACTOR MODULATES THE SEVERITY OF COGNITIVE ALTERATIONS INDUCED BY MUTANT huntingtin: INVOLVEMENT OF PHOSPHOLIPASECγ ACTIVITY AND GLUTAMATE RECEPTOR EXPRESSION
A. Giralt et al.
NEUROSCIENCE (2009)
Short-Term Striatal Gene Expression Responses to Brain-Derived Neurotrophic Factor Are Dependent on MEK and ERK Activation
Ozgun Gokce et al.
PLOS ONE (2009)
The complexity of mitogen-activated protein kinases (MAPKs) made simple
M. Krishna et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Mitogen- and stress-activated protein kinase-1 deficiency is involved in expanded-huntingtin-induced transcriptional dysregulation and striatal death
Emmanuel Roze et al.
FASEB JOURNAL (2008)
Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease
Judit Pallos et al.
HUMAN MOLECULAR GENETICS (2008)
Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice
Kusumika Gharami et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease
Chiara Zuccato et al.
BRAIN PATHOLOGY (2008)
Inhibitors of metabolism rescue cell death in Huntington's disease models
Hemant Varma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Glutamate induces histone H3 phosphorylation but not acetylation in striatal neurons:: role of mitogen- and stress-activated kinase-1
Karen Brami-Cherrier et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Regulation of mitogen-activated protein kinases by glutamate receptors
John Q. Wang et al.
JOURNAL OF NEUROCHEMISTRY (2007)
The role of glutamate in central nervous system health and disease - A review
Simon R. Platt
VETERINARY JOURNAL (2007)
Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory
Pamela Maher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
MAPK signalling: ERK5 versus ERK1/2
Satoko Nishimoto et al.
EMBO REPORTS (2006)
Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP-1 signalling pathways
Arianna L. Kim et al.
EXPERIMENTAL DERMATOLOGY (2006)
Caspases 3 and 7: Key mediators of mitochondrial events of apoptosis
SA Lakhani et al.
SCIENCE (2006)
Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate
DR Valenzano et al.
CURRENT BIOLOGY (2006)
Neurotrophin signalling in health and disease
MV Chao et al.
CLINICAL SCIENCE (2006)
Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1/2 protects against mutant huntingtin-associated toxicity
BL Apostol et al.
HUMAN MOLECULAR GENETICS (2006)
Huntingtin is cleaved by caspases in the cytoplasm and translocated to the nucleus via perinuclear sites in Huntington's disease patient lymphoblasts
A Sawa et al.
NEUROBIOLOGY OF DISEASE (2005)
Mechanism of human SIRT1 activation by resveratrol
MT Borra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Substrate-specific activation of sirtuins by resveratrol
M Kaeberlein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila
JC Liévens et al.
HUMAN MOLECULAR GENETICS (2005)
Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules
LR Gauthier et al.
CELL (2004)
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
KT Howitz et al.
NATURE (2003)
Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice
S Gines et al.
HUMAN MOLECULAR GENETICS (2003)
Roles and regulation of glutamate transporters in the central nervous system
RD O'Shea
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2002)
Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling
J Pouysségur et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Terminal glial differentiation involves regulated expression of the excitatory amino acid transporters in the Drosophila embryonic CNS
L Soustelle et al.
DEVELOPMENTAL BIOLOGY (2002)
Actions of PP2A on the MAP kinase pathway and apoptosis are mediated by distinct regulatory subunits
AM Silverstein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Lessons from animal models of Huntington's disease
DC Rubinsztein
TRENDS IN GENETICS (2002)
Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease
C Zuccato et al.
SCIENCE (2001)
Signal transduction pathways through TRK-A and TRK-B receptors in human neuroblastoma cells
T Sugimoto et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2001)
Brain-derived neurotrophic factor in Huntington disease
I Ferrer et al.
BRAIN RESEARCH (2000)
Selective high-affinity transport of aspartate by a Drosophila homologue of the excitatory amino-acid transporters
MT Besson et al.
CURRENT BIOLOGY (2000)